DATATRAK Announces New VP, Sees Immediate Results
DATATRAK International, Inc. (DATA) is a technology and services company that provides electronic clinical solutions for the clinical trials industry. Its software suite is used to collect, review, transmit, and store clinical trial data electronically.
On October 4th 2010, DATATRAK announced the hiring of William (Bill) Gluck, Ph.D., as the company's Vice President of Clinical and Consulting Services. Dr. Gluck, a thirty-year clinical trial industry veteran, will focus on building the company's consulting and clinical services business. Dr. Gluck has diversified experience in clinical trial management systems, electronic data capture and the services that surround these solutions.
Prior to joining DATATRAK, Dr. Gluck served in management roles in sponsor companies for over 18 years including Amgen, BASF Life Sciences, Gilead Sciences, and Triangle Pharmaceuticals. He also brings the perspective of the very important CRO organization having served in them for seven years. Finally, Dr. Gluck continues to apply his skills in academia in university settings.
On October 5th, 2010, DATATRAK announced the award of a consulting contract with an existing global research-based biopharmaceutical client to provide clinical data management and trial design services. With the award of this contract, DATATRAK is expanding its staff to include experienced clinical data managers to provide services under the direction of Dr. Bill Gluck.
Renewing with Existing Clients
On October 11th, the firm announced the signing of an Enterprise Agreement for three new Phase III oncology studies with an existing client. These multi-center studies will be deployed utilizing the unified DATATRAK eClinical platform.
Read the full analyst report on "DATA"
Zacks Investment Research
| Zacks Top Ten Stocks for 2011 are now available! This 10-stock portfolio is a well-balanced mix of aggressive and conservative, large and small cap, growth and value. Buy them. Hold them. Watch your gains add up |
|
Ride Momentum Stocks to Quick Gains! The market is finally breaking out, creating the perfectd wave for investing in momentum stocks. Zacks is the king of fundamental analysis, but this service also uses technical indicators for the best possible timing. Click here to learn more >>. |
| Take advantage of quick short-term moves, and profit from price moves in any direction. Trade options under the direction of an expert guide. Try it now and get a 90-day unconditional money-back guarantee. 50% OFF for a limited time! Zacks Options Trader >> |
|
No Stocks are Harder to Find, or More Worth the Effort. They have the greatest potential for quick gains, but they're also the most difficult to find and time correctly. Now Zacks has perfected a system for identifying and profiting from turnaround stocks just as they begin a powerful rebound. Learn more here >>. |

Read Zacks_Analysts' blog in RSS

October 12, 2010
Share This